The Arora Report

Rss Facebook Twitter Linkedin

Stock Market News To Give You An Edge

Proven Track Record of Most Accurate Analysis

Stock Market News
To Give You An Edge​

Proven Track Record
of Most Accurate Analysis

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

KBE: BANK STOCKS PROVIDE GOOD DIVERSIFICATION FOR HEAVILY AI WEIGHTED PORTFOLIO

October 17, 2025

By Nigam Arora Diversification Banks stocks provide good diversification for portfolios heavily weighted in AI. Positive Tailwinds The following are providing positive tailwinds for bank stocks: Robust capital markets High net interest income Strong loan growth Deregulation Earnings JPM, WFC, C, and GS kicked off earnings season today.  All banks reported earnings better than the consensus and inline with whisper numbers. ETF Of Choice The ETF of choice is KBE. Zones For those who are following the Good Way, the Buy Now rating is *** (To see the locked content, please take a 30 day free trial). For those following the

Read More »

HOW AI IMPACTS BANKS, JOBS MARKET

October 16, 2025

By Nigam Arora Nigam Arora returns to the Schwab Network and weighs in on job cuts in banks, saying AI will be a factor to increase productivity and could be the “fly in the ointment” for that segment of the labor market. Watch the interview for what investors need to know. To take a free 30-day trial to paid services to gain access to more opportunities, please click here. Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 1% of

Read More »

POWELL TRIGGERED STOCK BUYING OUTWEIGHS TRUMP POST ON SOYBEANS AND COOKING OIL, WALMART MOVES TO AGENTIC COMMERCE

October 15, 2025

By Nigam Arora To gain an edge, this is what you need to know today. Rate Cut Hopes Win Out Please click here for a chart of S&P 500 ETF (SPY) which represents the benchmark stock market index S&P 500 (SPX). Note the following: The chart shows the stock market drop on Friday on tensions heating up between the U.S. and China and TACO (Trump Always Chickens Out) traders running the stock market back up Monday morning. The chart shows Fed Chair Powell’s speech yesterday driving the stock market higher.  Fed Chair Powell’s speech indicated the Fed may cut interest rates

Read More »

TACO TRADERS MEET CAHN, BANK EARNINGS, NEW AMD WIN, AND RUSH TO BUY QUANTUM AND NUCLEAR STOCKS

October 14, 2025

By Nigam Arora To gain an edge, this is what you need to know today. TACO Traders Meet CAHN Please click here for a chart of JPMorgan Chase stock (JPM). Note the following: The Morning Capsule is about the big picture, not an individual stock.  The chart of JPM stock is being used to illustrate the point. The chart shows a rising trendline. The chart shows that going into earnings, JPM stock pulled back to the trendline. RSI on the chart shows JPM stock has more room to run. Expectations going into JPMorgan earnings were very high, but earnings beat the

Read More »

SHORT SQUEEZE IN SILVER AND RARE EARTHS, STOCK MARKET TACO TRADERS EUPHORIC, TRUMP SEEKS DIPLOMATIC PATH

October 13, 2025

By Nigam Arora To gain an edge, this is what you need to know today. Euphoric TACO Traders Please click here for a chart of S&P 500 ETF (SPY) which represents the benchmark stock market index S&P 500 (SPX). Note the following: The chart shows the big drop in the stock market on Friday on President Trump threatening to impose 100% additional tariffs on Chinese goods. In Friday’s Morning Capsule, when S&P 500 was trading at an all time high, we wrote: In yesterday’s Morning Capsule, we shared with you that China was restricting the export of rare earths to gain

Read More »

WEEKLY STOCK MARKET DIGEST: THE ARORA REPORT WARNED HOURS BEFORE BIG STOCK MARKET DROP

October 11, 2025

By Nigam Arora Editors Notes: Hours before Trump’s new tariffs news hit and S&P 500 dropped 2.7% as well as NASDAQ dropped 3.4%, The Arora Report warned: “History teaches a trigger often comes from nowhere” In the morning before the big drop in the stock market, The Arora Report issued a signal to paying members to increase the Arora Protection Band by raising hedges and selling some stocks. When markets tumbled, The Arora Report paying members were already ahead of the curve. Do you want to get ahead of the curve?   Weekly Digest from The Arora Report is popular

Read More »

WORLD’S SMARTEST BANKER THINKS 30% CHANCE OF STOCK MARKET CORRECTION BUT HERE IS WHAT HE IS NOT TELLING YOU

October 10, 2025

By Nigam Arora To gain an edge, this is what you need to know today. Correction Trigger Please click here for a chart of S&P 500 ETF (SPY) which represents the benchmark stock market index S&P 500 (SPX). Note the following: The chart shows the stock market is way above the 200 day moving average (shown in yellow). The chart shows zone 1 will act as support on any pullback. Jamie Dimon, CEO of JPMorgan Chase (JPM), is the smartest banker in the world.  Here are the key points from what Dimon is saying: Dimon thinks the chance of a correction

Read More »

CONGRATULATIONS! BIOTECH AKRO BUYOUT BY NVO BECOMES 213TH ARORA PORTFOLIO BUYOUT

October 9, 2025

By Nigam Arora NVO, the maker of weight loss drug Wegovy, is buying AKRO.  The deal is for $60 per share.  The deal consists of $54 per share in cash to be paid on closing and $6 per share in cash upon U.S. regulatory approval of efruxifermin drug cirrhosis. What To Do Now The stock is trading at $55.25 as of this writing in the premarket.  The contingent value rights (CVR) are likely to be illiquid and not traded.  Those deciding to hold have a good probability of ultimately receiving $6 per share in share for CVR.  To hold or to

Read More »

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content